Vijay Kasturi
Technik-/Wissenschafts-/F&E-Leiter bei CG ONCOLOGY, INC.
Vermögen: 47 603 $ am 30.04.2024
Profil
Vijay Kasturi is currently the Chief Medical Officer at CG Oncology, Inc. Prior to this, he was the Vice President-Clinical Development at AVEO Pharmaceuticals, Inc. from 2021 to 2023, the Head-Medical Affairs at EMD Serono, Inc. from 2015 to 2020, and the Senior Vice President-Scientific Affairs at FerGene, Inc. from 2020 to 2021.
Kasturi received his undergraduate degree from the University of Illinois and his doctorate from Rush Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0,00% | 25.03.2024 | 1 315 ( 0,00% ) | 47 603 $ | 30.04.2024 |
Aktive Positionen von Vijay Kasturi
| Unternehmen | Position | Beginn |
|---|---|---|
| CG ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2023 |
Ehemalige bekannte Positionen von Vijay Kasturi
| Unternehmen | Position | Ende |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2023 |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.03.2020 |
Ausbildung von Vijay Kasturi
| Rush Medical College | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
